Genmab (GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that Orbis Investment Management Limited has informed us that, as of September 19, 2025, Orbis Investment Management Limited through shares and ADRs, representing shares, controlled the voting rights to 3,230,732 shares in Genmab A/S, which amounts to 5.03% of the share capital and voting rights in Genmab A/S.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GMAB:
- Genmab upgraded to Buy at Guggenheim on royalty revenue upside potential
- Genmab upgraded to Buy from Neutral at Guggenheim
- Genmab price target raised to DKK 1,650 from DKK 1,500 at JPMorgan
- Genmab A/S Updates Articles of Association to Boost Financial Flexibility
- Genmab Announces Capital Increase Following Employee Warrant Exercise